Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Chemotherapy-induced organ toxicity mitigation

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the mechanisms of cisplatin-induced nephrotoxicity, including oxidative stress, apoptosis, inflammation, and mitochondrial dysfunction. It also explores various renoprotective strategies and potential interventions to mitigate kidney injury caused by cisplatin. The research covers a wide range of topics such as the role of specific antioxidants, inflammatory pathways, and cellular mechanisms involved in chemotherapy-induced kidney damage.

107
Works

How has Chemotherapy-induced organ toxicity mitigation's publication output changed over time?

ScholarIQpublication output · 2002–2022

Output grew100% over the shown period — from 1 works in 2002 to 2 in 2022.

1
1
1
2
1
1
2
2
1
2
2002200320052013201420152016201720182022

What are the most-cited papers on Chemotherapy-induced organ toxicity mitigation?

ScholarIQmost cited works
Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
Ying Zhou, Huitao Xu, Wenrong Xu, Bingying Wang, Huiyi Wu, Yang Tao, Bin Zhang, Mei Wang, Fei Mao, Yongmin Yan, Shuo Gao, Hongbing Gu, Wei Zhu, Hui Qian
S2061155. 2013671 CitationsOPEN ACCESS
Cisplatin-Associated Nephrotoxicity and Pathological Events
Takashi Taguchi, Arifa Nazneen, M. Ruhul Abid, Mohammed S. Razzaque
Contributions to nephrology. 2005259 Citations
Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death
Kazuhiko Tsuruya, Toshiharu Ninomiya, Masanori Tokumoto, Makoto Hirakawa, Kohsuke Masutani, Masatomo Taniguchi, Kyoichi Fukuda, Hidetoshi Kanai, Kenji Kishihara, Hideki Hirakata, Mitsuo Iida
Kidney International. 2003242 Citations
Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure
Didier Portilla, Gonghe Dai, Timothy McClure, Linda M. Bates, Richard C. Kurten, Judit Megyesi, Peter M. Price, Shenyang Li
Kidney International. 2002143 CitationsOPEN ACCESS

Where is Chemotherapy-induced organ toxicity mitigation research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Chemotherapy-induced organ toxicity mitigation is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
40%
Green
0%
Hybrid
13%
Bronze
7%
Closed
40%

Related on ScholarIQ

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Paper
Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
Paper
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Paper
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Paper
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
Paper
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Paper
470M+ articles · free account